MedPath

Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation Study

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Device: Blood Glucose Monitoring System Altitude Performance
Registration Number
NCT02916563
Lead Sponsor
LabStyle Innovations Ltd.
Brief Summary

This study evaluates the performance of a blood glucose monitoring system at high altitudes (approximately 10,000 feet). The performance is assessed via a reference method for glucose analysis (Yellow Springs Instrument 2300 STAT Plus Glucose Analyzer).

Detailed Description

This study will be a non-randomized study conducted to assess the accuracy and performance of the Dario Blood Glucose Monitoring System at an elevated altitude. 50 subjects will be enrolled in this study. Participation includes a 15-20 minute visit to the clinical site where they will be consented. The participant will then receive a fingerstick to obtain capillary blood used to test the performance of the BGMS and to obtain a comparative glucose measurement on the reference method, the Yellow Springs Instrument 2300 STAT Plus Glucose Analyzer.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Able to speak and read English
Exclusion Criteria
  • Pregnant
  • Has any condition that the principle investigator believes may interfere in the subject's participation in the trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AltitudeBlood Glucose Monitoring System Altitude PerformanceSingle arm study Blood Glucose Monitoring System Altitude Performance
Primary Outcome Measures
NameTimeMethod
Number of Successful Glucose ReadingsOne day

The success criterion for the performance of the Blood Glucose Monitoring System at high altitude (approximately 10,000 feet above sea level) means that 95% of the blood glucose readings fall within 15mg/dL of the YSI reference value (for reference values less than 75 mg/dL) and within 20% (for reference values greater than or equal to 75 mg/dL).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Barbara Davis Center

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath